Quickly add a free MyWikiBiz directory listing!

MyWikiBiz, Author Your Legacy — Sunday May 19, 2013

Biodel Upgraded to Buy by Ladenburg Thalmann (BIOD) – Mideast ... Biodel has a 1-year low of $2.13 and a 1-year high of $4.00. The stock's 50-day moving average is currently $2.77. The company's market cap is $44.0 million. Biodel Inc. (NASDAQ: BIOD) is a development-stage company. 14 May 2013 Hossein Forouzandeh

Pipeline updates for SUPN KYTH MACK TGTX CCXI. BIOD files ... BIODEL INC (NASDAQ:BIOD) entered into an At-the-Market Issuance Sales Agreement, with MLV, under which it may sell shares of its common stock on the open market up to the value of $14 million, from time to time. 14 May 2013 admin

Halozyme Therapeutics, Inc. - Product Pipeline Review - H2 2011 ... Inc. – Product Pipeline Review – H2 2011 Amylin Pharmaceuticals, Inc. Biodel Inc., H2 2012 53 Halozyme Therapeutics,. Books & Materials. MediQuest Therapeutics, Inc. Books & Materials. – Product Pipeline Review – H2 ... 13 May 2013 Mariusiii

Biodel's CEO Discusses F2Q13 Results - Earnings Call Transcript ... Marc Stutman – Trimark. Biodel Inc. (BIOD) F2Q13 Earnings Call May 8, 2013 8:00 AM ET ... I will now turn the conference call over to Paul Bavier, Biodel's Corporate Secretary and General Counsel. Paul Bavier. Thank you. 8 May 2013 SeekingAlpha.com

Danbury Roundup: Biodel Inc. Reports Second Quarter Fiscal Year ... Biodel Inc. Reports Second Quarter Fiscal Year 2013 Financial Results. Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! DANBURY, Conn., May 8, 2013 -- Biodel Inc. via Danbury ... 8 May 2013 Danbury Roundup

Downloads Biodel Inc. - Product Pipeline Review - Q4 2010 e-book ... Biodel Inc. - Product Pipeline Review - Q4 2010 book download Download Biodel Inc. - Product Pipeline Review - Q4 2010 Books & Materials, Colleges & Universities. Zosano Pharma, Inc. - Product. Table of Contents: Alcon, ... 16 April 2013 marquettaacfb

Nadia Kilkenny Download Biodel Inc. - Financial and Strategic ... Download Biodel Inc. - Financial and Strategic Analysis Review e-book. Biodel Inc. - Financial and Strategic Analysis Review book download. Biodel Inc. - Financial and Strategic Analysis Review Global Markets Direct ... 21 March 2013 nadiaupap

Biodel Inc. - Product Pipeline Review - 2012 - New Market Research ... Global Market Direct's pharmaceuticals report, "Biodel Inc. - Product Pipeline Review - 2012" provides data on the Biodel Inc.'s research and development focus. The report includes information on current developmental ... 13 February 2013 unknown

Biodel, Inc. (BIOD) Starts Presentation at 15th Annual BIO CEO ... Biodel is a specialty pharmaceutical company that is engaged in the development and commercialization of innovative treatments for diabetes that are potentially safer, more effective and more convenient for diabetic patients. 11 February 2013 Mission IR

Biodel Inc 10-K for FY ending 09/30/2012 - BondTools Biodel Inc 10-K for FY ending 09/30/2012. Biodel Inc reported no revenue for the year. A loss of $20.75 million for the year, represents a increase of 95.87% from the previous year loss. EPS came in at -1.91 versus the prior -1.36. Read the Full ... 21 December 2012 info@agorasys.com (Bondtools)

Name: Biodel Inc

Share this page